OMER compared with CORT: revenue, margins and what each company keeps, and the suppliers and customers both name

OMEROmeros Corp

Mkt capRevenueRevenue

CORTCorcept Therapeutics Inc

Mkt capRevenueRevenue

Compare

OMEROmeros Corp

CORTCorcept Therapeutics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OMER 9

NVONovo Nordisk Healthcarecustomer

—Lonza Biologics Tuas Pteunlistedsupplier

—Vetter Pharma International, GmbHunlistedsupplier

—Novo Nordisk Healthcareunlistedsupplier

5 more · OMER chain ›

Shared 0

No shared counterparties.

Only CORT 7

—Curant Health Georgiaunlistedsupplier

—Arcagy-Ginecounlistedsupplier

—Medpace Researchunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Optime

unlistedsupplier

3 more · CORT chain ›

OMEROmeros Corp

18.17▼−0.53%· post 18.34· delayed

Mkt cap$1.3BRevenue$29MQ2 FY26Revenue—

CORTCorcept Therapeutics Inc

79.04▼−3.53%· post 79.50· delayed

After hoursNov 4 '26delayed

Mkt cap$9.0BRevenue$340MQ3 FY26Revenue$761MFY25

Compare

After hoursNov 4 '26delayed

OMEROmeros Corp

CORTCorcept Therapeutics Inc

18.17▼−0.53%post 18.34delayed

Price

79.04▼−3.53%post 79.50delayed

$1.3B

Mkt cap

$9.0B

Q2 FY26$29M

Revenue

$340MQ3 FY26

—

Revenue

$761MFY25

OMER18.17▼−0.53%vsCORT79.04▼−3.53%After hoursNov 4 '26delayed